Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May;48(5):651-656.
doi: 10.1111/1346-8138.15714. Epub 2021 Feb 23.

Dermatological manifestations during COVID-19 and histological picture: Description of two clinical cases

Affiliations

Dermatological manifestations during COVID-19 and histological picture: Description of two clinical cases

Paola Mencarini et al. J Dermatol. 2021 May.

Abstract

It is not yet entirely clear what is the relevance of skin symptoms and what clinical implications are related to their appearance in COVID-19 patients. We describe two cases of COVID-19-associated pneumonia, which presented skin manifestations in advanced stage of illness, when nasopharyngeal swabs became negative for SARS-CoV-2. The first case presented erythematous, maculopapular lesions; the second developed petechial, vesicular and blood-encrusted lesions on the limbs. Histopathology documented perivascular lymphocytic infiltrates, with prevalent CD4+ T-cells in both patients. The research of SARS-CoV-2 in tissues with real time RT-PCR was negative. Basal keratinocytes displayed C4d deposits in one case, who developed laboratory signs indicative of a procoagulative condition at the same time as the skin rash. Skin manifestations during SARS-CoV-2 infection seem to be clinically relevant and further studies are necessary to assess if they are linked to systemic complications, lack of viral clearance or cascades of immune responses induced by the virus, even in patients affected by mild pneumonia.

Keywords: COVID-19; SARS-CoV-2 infection; inflammation markers; rash; skin biopsy.

PubMed Disclaimer

Conflict of interest statement

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Figures

Figure 1
Figure 1
(a) Case 1, day 20. Skin rash with initial seborrheic‐like flaking of the face and scalp and following diffusion to suberythrodermic appearance; (b,c) Case 2, day 39. Petechial and crusty lesions on the lower limbs
Figure 2
Figure 2
Skin slides Case 1. (a) H&E‐stained sections reveal an extensive dermal–epidermal inflammatory perivascular infiltrate; (b) basal keratinocytes display C4d deposits, note absence of C4d on endothelial cells. (c,d) Most lymphocytes are CD4+ cells, while fewer lymphocytes are CD8 positive. (e) CD68+ macrophages were observed in various locations throughout the dermis, particularly in the perivascular areas. (f) FXIIIa is expressed in both inflammatory cells and fibroblasts. Bars: a, b = 14 um; c, d, e, f = 50 um
Figure 3
Figure 3
Skin slides Case 2. (a) H&E‐stained sections reveal lymphocytic inflammation targeting the vessels wall of the derma, without significant wall damage; (b) faint C4d staining is present; (c, d) most lymphocytes are CD4+ cells, while fewer lymphocytes are CD8 positive; (e) CD68+ macrophages were observed particularly in the perivascular areas; (f) FXIIIa is expressed in both inflammatory cells and fibroblasts. Bars: a, c, d, e, f = 50 um; b = 14 um

References

    1. Guan WJ, Ni ZY, Hu Y et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382(18): 1708–1720. - PMC - PubMed
    1. Magro C, Mulvey JJ, Berlin D et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID‐19 infection: a report of five cases. Transl Res 2020; 220: 1–13. - PMC - PubMed
    1. Varga Z, Flammer AJ, Steiger P et al. Endothelial cell infection and endotheliitis in COVID‐19. Lancet 2020; 395(10234): 1417–1418. - PMC - PubMed
    1. Zhang Y, Cao W, Xiao M et al. Clinical and coagulation characteristics of 7 patients with critical COVID‐2019 pneumonia and acro‐ischemia. Zhonghua Xue Ye Xue Za Zhi 2020; 41: E006. - PubMed
    1. Recalcati S. Cutaneous manifestations in COVID‐19: a first perspective. J Eur Acad Dermatol Venereol 2020; 34(5): e212–e213. - PubMed

Grants and funding